Table 4.
Multivariate analysis of risk factors for MAFLD.
| Variables | Coefficient | Standard Error | Odds Ratio (95%CI) | p Value |
|---|---|---|---|---|
| Physical Activity | ||||
| Moderately active | −0.011 | 0.090 | 0.988 (0.829–1.179) | 0.898 |
| Active | −0.446 | 0.097 | 0.640 (0.529–0.775) | <0.001 |
| BMI, kg/m2 | 0.175 | 0.014 | 1.192 (1.160–1.224) | <0.001 |
| Waist circumference, cm | 0.049 | 0.005 | 1.050 (1.040–1.060) | <0.001 |
| HGB, g/L | 0.007 | 0.002 | 1.007 (1.004–1.011) | <0.001 |
| PLT, ×109/L | 0.002 | <0.001 | 1.002 (1.002–1.003) | <0.001 |
| LYMPH%,% | 0.012 | 0.004 | 1.012 (1.005–1.019) | <0.001 |
| TG, μmol/L | 0.138 | 0.025 | 1.148 (1.092–1.207) | <0.001 |
| HDL-C, mmol/L | −0.648 | 0.106 | 0.523 (0.425–0.644) | <0.001 |
| FPG, mmol/L | 0.104 | 0.017 | 1.110 (1.073–1.148) | <0.001 |
| SUA, μmol/L | 0.002 | <0.001 | 1.002 (1.001–1.003) | <0.001 |
MAFLD: metabolic associated fatty liver disease; BMI: body mass index; HGB: hemoglobin; PLT: platelet count; LYMPH%: percentage of lymphocytes; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; FPG: fasting plasma glucose; SUA: serum uric acid.